METHOD OF CORRECTION OF IMMUNOLOGICAL STATUS OF PATIENTS WITH LUNG CANCER

medicine, oncology. SUBSTANCE: invention proposes to the of use relanium (diazepam) in the dose 5 mg, three times per a day for 7 days. Invention can be used for correction of immunological status of patients with lung cancer. EFFECT: enhanced effectiveness of lung cancer immunotherapy. 1 tbl

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BAZANOV G.A, MOKHOV E.M, MARASANOV S.B
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:medicine, oncology. SUBSTANCE: invention proposes to the of use relanium (diazepam) in the dose 5 mg, three times per a day for 7 days. Invention can be used for correction of immunological status of patients with lung cancer. EFFECT: enhanced effectiveness of lung cancer immunotherapy. 1 tbl